Get the latest Science News and Discoveries

Melatonin: A potential nighttime guardian against Alzheimer’s (2024)


In the context of the escalating global health challenge posed by Alzheimer’s disease (AD), this comprehensive review considers the potential of melatonin in both preventive and therapeutic capacities. As a naturally occurring hormone and robust antioxidant, accumulating evidence suggests melatonin is a compelling candidate to consider in the context of AD-related pathologies. The review considers several mechanisms, including potential effects on amyloid-beta and pathologic tau burden, antioxidant defense, immune modulation, and regulation of circadian rhythms. Despite its promise, several gaps need to be addressed prior to clinical translation. These include conducting additional randomized clinical trials in patients with or at risk for AD dementia, determining optimal dosage and timing, and further determining potential side effects, particularly of long-term use. This review consolidates existing knowledge, identifies gaps, and suggests directions for future research to better understand the potential of melatonin for neuroprotection and disease mitigation within the landscape of AD.

None

Get the Android app

Or read this on r/EverythingScience

Read more on:

Photo of Melatonin

Melatonin

Photo of Alzheimer

Alzheimer

Related news:

News photo

Molecule restores cognition, memory in Alzheimer's disease model mice

News photo

Dopamine treatment alleviates symptoms in Alzheimer's disease

News photo

Reviving Brain Circuits: UCLA Scientists Discover Memory-Restoring Molecule for Alzheimer’s Disease